Effects of topical gel Silymarin versus placebo as an adjuvant therapy on pain management in patients with painful diabetic neuropathy
Phase 3
- Conditions
- Painful diabetic neuropathy.Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecifiedE08.40
- Registration Number
- IRCT20120215009014N501
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Age of 18 to 65 years
Diabetes mellitus type 1 or 2
Painful diabetic neuropathy
Exclusion Criteria
Pregnancy or breastfeeding
Drug abuse
Nondiabetic neuropathy
Diabetic ulcer
Liver or kidney disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method